Israel Englander Maravai Lifesciences Holdings, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 4,325,312 shares of MRVI stock, worth $22.6 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

4,325,312

Previous 5,968,592 27.53%

Holding current value

$22.6 Million

Previous $42.7 Million 15.89%

% of portfolio

0.02%

Previous 0.02%

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.84 - $9.73 $11.2 Million - $16 Million	-1,643,280 Reduced 27.53%	4,325,312 $35.9 Million
Q2 2024 Aug 14, 2024	BUY	$6.87 - $11.34 $4.9 Million - $8.09 Million	713,639 Added 13.58%	5,968,592 $42.7 Million
Q1 2024 May 15, 2024	SELL	$5.11 - $8.76 $2.72 Million - $4.66 Million	-531,896 Reduced 9.19%	5,254,953 $45.6 Million
Q4 2023 Feb 14, 2024	BUY	$4.7 - $9.87 $26.2 Million - $54.9 Million	5,565,436 Added 2513.6%	5,786,849 $37.9 Million
Q2 2023 Aug 14, 2023	BUY	$12.09 - $15.0 $2.55 Million - $3.17 Million	211,020 Added 2030.41%	221,413 $2.75 Million
Q1 2023 May 15, 2023	SELL	$12.99 - $16.48 $33.6 Million - $42.6 Million	-2,585,155 Reduced 99.6%	10,393 $146,000
Q4 2022 Feb 14, 2023	BUY	$12.5 - $24.78 $9.99 Million - $19.8 Million	799,274 Added 44.5%	2,595,548 $37.1 Million
Q3 2022 Nov 14, 2022	BUY	$20.6 - $30.37 $34.8 Million - $51.2 Million	1,687,021 Added 1544.14%	1,796,274 $45.9 Million

Others Institutions Holding MRVI

# of Institutions

235

Shares Held

141M

Call Options Held

223K

Put Options Held

19.4K

View Full List

About MARAVAI LIFESCIENCES HOLDINGS, INC.

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $687M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

More about MRVI

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account